- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT02704845
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain
Biopsychosocial Exploration of Pain Profiles in Inflammatory and Chronic Non-specific Axial Low Back Pain: An Exploration of Similarities and Differences
Studieoversikt
Status
Detaljert beskrivelse
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
-
Dublin, Irland, D24
- Physiotherapy Department, Adelaide and Meath Incorporating the National Children's Hospital (Tallaght Hospital)
-
Dublin, Irland, D8
- Ankylosing Spondylitis clinic, Rheumatology Department, St. James's Hospital
-
Dublin, Irland, D8
- Physiotherapy Department, St. James's Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
A convenience sample of adults with Ankylosing Spondylitis (AS) will be consecutively recruited from a pool of patients referred to AS clinic in the Rheumatology and Physiotherapy Departments of St. James's and Tallaght Hospitals in Dublin.
Adults with chronic non-specifi low back pain (CNSLBP) (control group) will be consecutively recruited from a pool of patients referred to the Physiotherapy Department of St. James's and Tallaght Hospitals in Dublin. An invitation to participate in the study and an information leaflet will be extended to the patients who potentially meet the recruitment criteria.
Beskrivelse
Inclusion Criteria:
- Adult between 18 and 65 years of age
- Low back pain >3 months
- On stable medication
- Ability to walk independently without an assistive device
- Specific inclusion criteria for AS group: clinical diagnosis of ankylosing spondylitis by a rheumatologist
- Specific inclusion for CNSLBP group: clinical diagnosis by a physician for CLBP
Exclusion Criteria:
- Spinal surgery or compression fracture within the last 6 months
- Cauda equine and conus medullaris syndromes
- Severe musculoskeletal conditions affecting the upper and/or the lower limbs, such as severe inflammatory arthritis of the peripheral joints
- Severe osteoporosis
- Leg-length discrepancy
- Cancer
- Morbid obesity, or pregnancy
- Progressive neurological disease
- Psychiatric disease and/or cognitive limitations that could affect the ability to complete the study questionnaires
- Inability to read and/or understand the English language
- Severe cardiac, respiratory or neurological diseases
- Uncontrolled epilepsy
- Specific exclusion criteria for CNSLBP group: Spondyloarthropathy, or any structural abnormalities in the lumbar spine that result in serious neurological dysfunction, such as stage III-IV lumbar disc herniation, and grade III-IV spondylolisthesis
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
|---|
|
Ankyloserende spondylitt
|
|
Chronic non-specific low back pain
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Back pain intensity - total
Tidsramme: Day 1, no follow-up will be required.
|
The average total back pain intensity in the last week will be measured by the Numeric Rating Scale (NRS)
|
Day 1, no follow-up will be required.
|
|
Back pain-related functional disability
Tidsramme: Day 1, no follow-up will be required.
|
Oswestry Disability Index (ODI)
|
Day 1, no follow-up will be required.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Back pain beliefs
Tidsramme: Day 1, no follow-up will be required.
|
Back Beliefs Questionnaire (BBQ)
|
Day 1, no follow-up will be required.
|
|
Pain-related fear, fear of movement/(re)injury
Tidsramme: Day 1, no follow-up will be required.
|
Tampa Scale for Kinesiophobia (TSK)
|
Day 1, no follow-up will be required.
|
|
The fear-avoidance behaviours of physical activity
Tidsramme: Day 1, no follow-up will be required.
|
modified Fear Avoidance Behaviour Questionnaire (mFABQ)
|
Day 1, no follow-up will be required.
|
|
Pain catastrophizing behavior
Tidsramme: Day 1, no follow-up will be required.
|
Pain catastrophizing scale (PCS)
|
Day 1, no follow-up will be required.
|
|
Self-efficacy for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Ankylosing Spondylitis-specific Arthritis Self-Efficacy Scale (ASES-AS)
|
Day 1, no follow-up will be required.
|
|
Pain cognition and coping
Tidsramme: Day 1, no follow-up will be required.
|
Pain Coping Inventory (PCI)
|
Day 1, no follow-up will be required.
|
|
Psychological distress (depression & anxiety)
Tidsramme: Day 1, no follow-up will be required.
|
Hospital Anxiety and Depression Scale (HADS)
|
Day 1, no follow-up will be required.
|
|
The extent and location of pain
Tidsramme: Day 1, no follow-up will be required.
|
Pain drawings will be completed for NSCLBP patients on a digital tablet (iPad 2, Apple Computer, Cupertino, CA, USA) using a commercially available sketching software (SketchBook)
|
Day 1, no follow-up will be required.
|
|
Back pain intensity - nocturnal
Tidsramme: Day 1, no follow-up will be required.
|
The average nocturnal back pain intensity in the last week will be measured by the Numeric Rating Scale (NRS)
|
Day 1, no follow-up will be required.
|
|
Physical function for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Bath Ankylosing Spondylitis Functional Index (BASFI)
|
Day 1, no follow-up will be required.
|
|
Disease activity for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Bath Ankylosing Spondylitis Disease Activity Index (BASDAI)
|
Day 1, no follow-up will be required.
|
|
Disease activity for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Ankylosing Spondylitis Disease Activity Score (ASDAS)
|
Day 1, no follow-up will be required.
|
|
Global well-being for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Bath Ankylosing Spondylitis Global score (BAS-G)
|
Day 1, no follow-up will be required.
|
|
Flexibility and spinal mobility for AS patients
Tidsramme: Day 1, no follow-up will be required.
|
Bath Ankylosing Spondylitis Metrology Index (BASMI)
|
Day 1, no follow-up will be required.
|
|
Chest expansion
Tidsramme: Day 1, no follow-up will be required.
|
Chest expansion will be measured circumferentially using a tape measure
|
Day 1, no follow-up will be required.
|
|
Forward bending
Tidsramme: Day 1, no follow-up will be required.
|
Finger-to-Floor Distance in centimetres (cm) will be measured using a tape measure
|
Day 1, no follow-up will be required.
|
|
Isometric endurance of the trunk extensor muscles
Tidsramme: Day 1, no follow-up will be required.
|
Ito test
|
Day 1, no follow-up will be required.
|
|
Isometric endurance of the the trunk flexor muscles
Tidsramme: Day 1, no follow-up will be required.
|
Shirado test
|
Day 1, no follow-up will be required.
|
|
Grip strength
Tidsramme: Day 1, no follow-up will be required.
|
Hand grip dynamometer (Jamar Hydraulic Hand Dynamometer)
|
Day 1, no follow-up will be required.
|
|
Functional performance
Tidsramme: Day 1, no follow-up will be required.
|
50-foot walk test
|
Day 1, no follow-up will be required.
|
|
Functional performance and endurance
Tidsramme: Day 1, no follow-up will be required.
|
6-min walk distance (6MWD) test
|
Day 1, no follow-up will be required.
|
Samarbeidspartnere og etterforskere
Etterforskere
- Hovedetterforsker: Fiona Wilson, Trinity College Dublin, Ireland
- Hovedetterforsker: Lolwah A Al-Rashed, Trinity College Dublin, Ireland
- Hovedetterforsker: Finbar O'Shea, St. James's Hospital, Dublin, Ireland
- Hovedetterforsker: Deborah Falla, University Medical Center Göttingen, Georg-August University, Göttingen, Germany
- Hovedetterforsker: Marco Barbero, University of Applied Sciences and Arts of Southern Switzerland (SUPSI), Manno, Switzerland
- Hovedetterforsker: Aisling Brenan, Adelaide and Meath Hospital Dublin incorporating the National Children's Hospital (Tallaght Hospital), Dublin, Ireland
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- UDublinTC 12
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .